Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, Ohio.
College of Medicine, University of the Philippines Manila, Manila, Philippines.
Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E689-E700. doi: 10.1152/ajpendo.00174.2019. Epub 2020 Mar 10.
Hypoxia leading to stabilization of hypoxia-inducible factor 1α (HIF-1α) serves as an early upstream initiator for adipose tissue (AT) dysfunction. Monocyte-derived macrophage infiltration in AT contributes to inflammation, fibrosis and obesity-related metabolic dysfunction. It was previously reported that myeloid cell-specific deletion of protected against high-fat diet (HFD)-induced AT dysfunction. Prolyl hydroxylases (PHDs) are key regulators of HIF-1α. We examined the effects of myeloid cell-specific upregulation and stabilization of via deletion of prolyl-hydroxylase 2 () and whether interleukin-1 receptor associated kinase-M (), a known downstream target of , contributes to -induced AT dysfunction. Our data show that with HFD, and expressions were increased in the AT macrophages of / mice compared with mice. With HFD, / mice exhibited increased AT inflammation, fibrosis, and systemic insulin resistance compared with control mice. Furthermore, / mice bone marrow-derived macrophages exposed to hypoxia in vitro also had increased expressions of both and . In wild-type mice, HFD induced upregulation of both and in adipose tissue. Despite equivalent expression of compared with wild-type mice, globally-deficient mice fed a HFD exhibited less macrophage infiltration, decreased inflammation and fibrosis and improved glucose tolerance. Global deficiency was associated with an alternatively-activated macrophage phenotype in the AT after HFD. Together, these data show for the first time that an -dependent mechanism likely mediates obesity-related AT dysfunction in conjunction with upregulation.
缺氧导致缺氧诱导因子 1α(HIF-1α)稳定,作为脂肪组织(AT)功能障碍的早期上游启动子。单核细胞衍生的巨噬细胞浸润 AT 导致炎症、纤维化和肥胖相关的代谢功能障碍。先前有报道称,髓样细胞特异性缺失 可防止高脂肪饮食(HFD)诱导的 AT 功能障碍。脯氨酰羟化酶(PHDs)是 HIF-1α的关键调节剂。我们研究了通过删除脯氨酰-羟化酶 2()特异性上调和稳定髓样细胞中 以及是否白细胞介素-1 受体相关激酶-M(), 的已知下游靶点,是否有助于 诱导的 AT 功能障碍。我们的数据表明,与 HFD 相比,/ 小鼠的 AT 巨噬细胞中 和 的表达增加。与对照小鼠相比,/ 小鼠在 HFD 下表现出增加的 AT 炎症、纤维化和全身胰岛素抵抗。此外,在体外缺氧条件下暴露于 HFD 的 / 小鼠骨髓来源的巨噬细胞也表现出 和 的表达增加。在野生型小鼠中,HFD 诱导脂肪组织中 和 的上调。尽管与野生型小鼠相比 表达相当,但接受 HFD 的全身性 缺陷小鼠的巨噬细胞浸润减少、炎症和纤维化减少、葡萄糖耐量改善。HFD 后 AT 中存在替代激活的巨噬细胞表型与全局 缺陷相关。总之,这些数据首次表明,- 依赖性机制可能与 上调一起介导肥胖相关的 AT 功能障碍。